← SynDRA
Skepinone-L
SynDRA canonical compound SYN0033967 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | MAPK14 |
|---|
| Mechanism of action | P38 MAPK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- 2-(2,4-DIFLUOROPHENYLAMINO)-7-[2R-,3-DIHYDROXYPROPOXY]-10,11-DIHYDRO-DIBENZO[A,D]-CYCLOHEPTEN-5-ONE
- CBS3830
- L-SKEPINONE
- RefChem:183340
- C24H21F2NO4
- 3que
- 3FF
- orb1301048
- SCHEMBL2686103
- SCHEMBL29527315
- SCHEMBL30197623
- GLXC-03725
- EX-A2161
- BDBM50392175
- EBC-24096
- s7214
- AKOS027422745
- CCG-268943
- CS-0941
- AC-35955
- AS-79383
- HY-15300
- SW219942-1
- T6130
- BRD-K83607951-001-02-2
- Z2235802136
- 2-[(2,4-Difluorophenyl)amino]-7-[(2R)-2,3-dihydroxypropoxy]-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-one
- 2-[(2,4-difluorophenyl)amino]-7-{[(2R)-2,3-dihydroxypropyl]oxy}-10,11-dihydro-5H-dibenzo[a,D][7]annulen-5-one
Look up Skepinone-L in the interactive SynDRA portal →